BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hensbergen AW, van Willigen DM, van Beurden F, van Leeuwen PJ, Buckle T, Schottelius M, Maurer T, Wester HJ, van Leeuwen FWB. Image-Guided Surgery: Are We Getting the Most Out of Small-Molecule Prostate-Specific-Membrane-Antigen-Targeted Tracers? Bioconjug Chem 2020;31:375-95. [PMID: 31855410 DOI: 10.1021/acs.bioconjchem.9b00758] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Boekestijn I, van Oosterom MN, Dell'Oglio P, van Velden FHP, Pool M, Maurer T, Rietbergen DDD, Buckle T, van Leeuwen FWB. The current status and future prospects for molecular imaging-guided precision surgery. Cancer Imaging 2022;22:48. [PMID: 36068619 DOI: 10.1186/s40644-022-00482-2] [Reference Citation Analysis]
2 Wu L, Zhao Q, Wang Q, Zhang Q, Yang F, Zheng B, Hu H, Xing N. Membrane dual-targeting probes: A promising strategy for fluorescence-guided prostate cancer surgery and lymph node metastases detection. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.07.018] [Reference Citation Analysis]
3 McDonagh AW, McNeil BL, Rousseau J, Roberts RJ, Merkens H, Yang H, Bénard F, Ramogida CF. Development of a multi faceted platform containing a tetrazine, fluorophore and chelator: synthesis, characterization, radiolabeling, and immuno-SPECT imaging. EJNMMI Radiopharm Chem 2022;7:12. [PMID: 35666363 DOI: 10.1186/s41181-022-00164-1] [Reference Citation Analysis]
4 Wang H, He Z, Liu X, Huang Y, Hou J, Zhang W, Ding D. Advances in Prostate‐Specific Membrane Antigen (PSMA)‐Targeted Phototheranostics of Prostate Cancer. Small Structures. [DOI: 10.1002/sstr.202200036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yılmaz B, Şahin S, Ergül N, Çolakoğlu Y, Baytekin HF, Sökmen D, Tuğcu V, Taşçı Aİ, Çermik TF. 99mTc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients. Ann Nucl Med. [DOI: 10.1007/s12149-022-01741-9] [Reference Citation Analysis]
6 Zhou J, Chen L, Chen L, Zeng X, Zhang Y, Yuan Y. Emerging role of nanoparticles in the diagnostic imaging of gastrointestinal cancer. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.04.009] [Reference Citation Analysis]
7 Kubeil M, Martínez IIS, Bachmann M, Kopka K, Tuck KL, Stephan H. Dual-Labelling Strategies for Nuclear and Fluorescence Molecular Imaging: Current Status and Future Perspectives. Pharmaceuticals 2022;15:432. [DOI: 10.3390/ph15040432] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Dell'Oglio P, van Willigen DM, van Oosterom MN, Bauwens K, Hensbergen F, Welling MM, van der Stadt H, Bekers E, Pool M, van Leeuwen P, Maurer T, van Leeuwen FWB, Buckle T. Feasibility of fluorescence imaging at microdosing using a hybrid PSMA tracer during robot-assisted radical prostatectomy in a large animal model. EJNMMI Res 2022;12:14. [PMID: 35254544 DOI: 10.1186/s13550-022-00886-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Derks YHW, van Lith SAM, Amatdjais-Groenen HIV, Wouters LWM, Kip A, Franssen GM, Laverman P, Löwik DWPM, Heskamp S, Rijpkema M. Theranostic PSMA ligands with optimized backbones for intraoperative multimodal imaging and photodynamic therapy of prostate cancer. Eur J Nucl Med Mol Imaging 2022. [PMID: 35029739 DOI: 10.1007/s00259-022-05685-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Derks YHW, Rijpkema M, Amatdjais-Groenen HIV, Loeff CC, de Roode KE, Kip A, Laverman P, Lütje S, Heskamp S, Löwik DWPM. Strain-Promoted Azide-Alkyne Cycloaddition-Based PSMA-Targeting Ligands for Multimodal Intraoperative Tumor Detection of Prostate Cancer. Bioconjug Chem 2021. [PMID: 34957825 DOI: 10.1021/acs.bioconjchem.1c00537] [Reference Citation Analysis]
11 Petrov SA, Zyk NY, Machulkin AE, Beloglazkina EK, Majouga AG. PSMA-targeted low-molecular double conjugates for diagnostics and therapy. Eur J Med Chem 2021;225:113752. [PMID: 34464875 DOI: 10.1016/j.ejmech.2021.113752] [Reference Citation Analysis]
12 Youssef A, Haskali MB, Gorringe KL. The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic. Cancers (Basel) 2021;13:5596. [PMID: 34830751 DOI: 10.3390/cancers13225596] [Reference Citation Analysis]
13 Zhang J, Rakhimbekova A, Duan X, Yin Q, Foss CA, Fan Y, Xu Y, Li X, Cai X, Kutil Z, Wang P, Yang Z, Zhang N, Pomper MG, Wang Y, Bařinka C, Yang X. A prostate-specific membrane antigen activated molecular rotor for real-time fluorescence imaging. Nat Commun 2021;12:5460. [PMID: 34526506 DOI: 10.1038/s41467-021-25746-6] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
14 Martin KE, Cosby AG, Boros E. Multiplex and In Vivo Optical Imaging of Discrete Luminescent Lanthanide Complexes Enabled by In Situ Cherenkov Radiation Mediated Energy Transfer. J Am Chem Soc 2021;143:9206-14. [PMID: 34114809 DOI: 10.1021/jacs.1c04264] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Berrens AC, van Leeuwen PJ, Maurer T, Hadaschik BA, Krafft U. Implementation of radioguided surgery in prostate cancer. Q J Nucl Med Mol Imaging 2021;65:202-14. [PMID: 34105337 DOI: 10.23736/S1824-4785.21.03348-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 DE Vries HM, Schottelius M, Brouwer OR, Buckle T. The role of fluorescent and hybrid tracers in radioguided surgery in urogenital malignancies. Q J Nucl Med Mol Imaging 2021;65:261-70. [PMID: 34057342 DOI: 10.23736/S1824-4785.21.03355-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Buckle T, Hensbergen AW, van Willigen DM, Bosse F, Bauwens K, Pelger RCM, van Leeuwen FWB. Intraoperative visualization of nerves using a myelin protein-zero specific fluorescent tracer. EJNMMI Res 2021;11:50. [PMID: 34052912 DOI: 10.1186/s13550-021-00792-9] [Reference Citation Analysis]
18 Zhang L, Shi X, Li Y, Duan X, Zhang Z, Fu H, Yang X, Tian J, Hu Z, Cui M. Visualizing Tumors in Real Time: A Highly Sensitive PSMA Probe for NIR-II Imaging and Intraoperative Tumor Resection. J Med Chem 2021;64:7735-45. [PMID: 34047189 DOI: 10.1021/acs.jmedchem.1c00444] [Reference Citation Analysis]
19 Kwon YD, Oh JM, Chun S, Kim HK. Synthesis and evaluation of multivalent nitroimidazole-based near-infrared fluorescent agents for neuroblastoma and colon cancer imaging. Bioorg Chem 2021;113:104990. [PMID: 34051414 DOI: 10.1016/j.bioorg.2021.104990] [Reference Citation Analysis]
20 Würnschimmel C, Wenzel M, Maurer T, Valdés Olmos RA, Vidal-Sicart S. Contemporary update of SPECT tracers and novelties in radioguided surgery: a perspective based on urology. Q J Nucl Med Mol Imaging 2021;65:215-28. [PMID: 33829716 DOI: 10.23736/S1824-4785.21.03345-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Aras O, Demirdag C, Kommidi H, Guo H, Pavlova I, Aygun A, Karayel E, Pehlivanoglu H, Yeyin N, Kyprianou N, Chen N, Harmsen S, Sonmezoglu K, Lundon DJ, Oklu R, Ting R, Tewari A, Akin O, Sayman HB. Small Molecule, Multimodal, [18F]-PET and Fluorescence Imaging Agent Targeting Prostate-Specific Membrane Antigen: First-in-Human Study. Clin Genitourin Cancer 2021:S1558-7673(21)00074-4. [PMID: 33879400 DOI: 10.1016/j.clgc.2021.03.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Knipper S, Ascalone L, Ziegler B, Hohenhorst JL, Simon R, Berliner C, van Leeuwen FWB, van der Poel H, Giesel F, Graefen M, Eiber M, Heck MM, Horn T, Maurer T. Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy. Eur Urol 2021;79:537-44. [PMID: 33317857 DOI: 10.1016/j.eururo.2020.11.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
23 Li Y, Zhou Y, Yue X, Dai Z. Cyanine Conjugate-Based Biomedical Imaging Probes. Adv Healthc Mater 2020;9:e2001327. [PMID: 33000915 DOI: 10.1002/adhm.202001327] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
24 Álamo P, Pallarès V, Céspedes MV, Falgàs A, Sanchez JM, Serna N, Sánchez-García L, Voltà-Duràn E, Morris GA, Sánchez-Chardi A, Casanova I, Mangues R, Vazquez E, Villaverde A, Unzueta U. Fluorescent Dye Labeling Changes the Biodistribution of Tumor-Targeted Nanoparticles. Pharmaceutics 2020;12:E1004. [PMID: 33105866 DOI: 10.3390/pharmaceutics12111004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
25 Muthumanickam S, Indhumathi T, Boomi P, Balajee R, Jeyakanthan J, Anand K, Ravikumar S, Kumar P, Sudha A, Jiang Z. In silico approach of naringin as potent phosphatase and tensin homolog (PTEN) protein agonist against prostate cancer. J Biomol Struct Dyn 2020;:1-10. [PMID: 33034258 DOI: 10.1080/07391102.2020.1830855] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
26 Collamati F, van Oosterom MN, De Simoni M, Faccini R, Fischetti M, Mancini Terracciano C, Mirabelli R, Moretti R, Heuvel JO, Solfaroli Camillocci E, van Beurden F, van der Poel HG, Valdes Olmos RA, van Leeuwen PJ, van Leeuwen FWB, Morganti S. A DROP-IN beta probe for robot-assisted 68Ga-PSMA radioguided surgery: first ex vivo technology evaluation using prostate cancer specimens. EJNMMI Res 2020;10:92. [PMID: 32761408 DOI: 10.1186/s13550-020-00682-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]